Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the U.S. Patent and Trademark Office has issued a new patent covering its lead investigational therapy, istaroxime, for intravenous ...

To raise crucial awareness, Fiona Loud, policy director at Kidney Care UK, has highlighted three common kidney problems ...

Thanks to medical advancements, heart attack deaths have dropped nearly 90% in the last 50 years. But deaths from these ...

In this high-yield, clinically focused session, Dr. Steven L. Cohn, one of the leading experts in perioperative medicine, ...

Decreases seen in mortality for acute MI, ischemic heart disease, while increases seen for mortality from other heart disease subtypes ...

If istaroxime is approved in the US for acute heart failure, this patent would provide protection to 2039 ...

Treat it like tobacco: avoid criminalizing it, discourage its use, and protect bystanders, says editorial. Cannabis use is ...

Beaufort Memorial Hospital is expanding its medical staff with a new orthopedic surgeon and a heart-specialist nurse ...

From 1970 to 2022, there was a decrease in heart disease mortality overall, but an increase in mortality from other heart ...

The Medical Center at Caverna, The Medical Center at Franklin and The Medical Center at Scottsville have all earned The Joint Commission’s Gold Seal of Approval for Acute Heart Attack Ready ...

Mesoblast plans to file a BLA for Revascor by year-end after aligning with FDA on trial design, potency assays, and ...

BOWLING GREEN, Ky. (WBKO) - Three rural hospitals have earned The Joint Commission’s Gold Seal of Approval® for Acute Heart ...